Genentech licenses UK package of small molecule drugs

London-based MRC Technology has inked a licensing pact with Genentech for a package of small molecule drug candidates for neurological conditions. MRC gets an unspecified upfront payment along with a slate of potential milestones for the licensing deal, the first major small molecule collaboration MRC has struck for its Centre for Therapeutics Discovery. CTD was formed a year ago from the MRC Technology Drug Discovery Group. MRC Technology not only works with targets from the U.K.'s Medical...